Douglas R. Deason - 06 Feb 2026 Form 3 Insider Report for Xerox Holdings Corp (XRX)

Reporting relationship: 10%+ Owner
Issuer ticker: XRX
Reported as of: 06 Feb 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 08 Apr 2026, 09:47:50 UTC
Prior SEC filing: 05 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Douglas R. Deason

Key filing fact

Douglas R. Deason filed Form 3 for Xerox Holdings Corp (XRX) on 08 Apr 2026.

Key facts

This page summarizes Douglas R. Deason's Form 3 filing for Xerox Holdings Corp (XRX).
0 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 08 Apr 2026, 09:47.

Change

Previous filing in this sequence was filed on 05 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001079500 Primary reporting owner

DEASON DOUGLAS R

Relationship: 10%+ Owner
Address: 3953 MAPLE AVE, SUITE 150, DALLAS
Signature: /s/ Douglas R. Deason
Signature date: 07 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XRX holding

Common Stock, $1.00 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,542,096
Date: 06 Feb 2026
Ownership: DD Revocable Trust
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XRX holding Derivative

Series A Convertible Perpetual Voting Preferred Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 06 Feb 2026
Ownership: DD Revocable Trust
Underlying class: 6,741,576 Shares of Common Stock
Underlying amount: 180,000
Exercise price
Footnotes: F1, F2

XRX holding Derivative

Warrants to Purchase Shares of Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 06 Feb 2026
Ownership: DD Revocable Trust
Underlying class: 7,641,828 Shares of Common Stock
Underlying amount: 7,641,828
Exercise price: $8.00
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Mr. Deason is a Co-Executor of the DD Revocable Trust (the "Trust") and has the power to direct the voting and disposition of the securities held by the Trust. Following the passing of Darwin Deason on December 2, 2025, the Trust became irrevocable by operation of law. On February 6, 2026, the appropriate court issued Letters Testamentary appointing Douglas R. Deason, Scott Letier, and Bryan C. Birkland as Co-Executors of the Trust. Mr. Deason is deemed to be the beneficial owner of the securities held by the Trust by virtue of his power to control the Trust. Mr. Deason disclaims beneficial ownership of all securities reported herein except to the extent of his pecuniary interest therein.

Footnote F2

Each share of Series A Convertible Perpetual Voting Preferred Stock ("Series A Preferred Stock") is convertible into shares of common stock, (the "Shares") at a conversion rate of approximately 37.4532 Shares per share of Series A Preferred Stock, subject to adjustment. The Series A Preferred Stock may be converted at any time at the election of the holder and does not have an expiration date.

Footnote F3

The Trust holds warrants to purchase shares of Common Stock (the "Warrants") distributed by the Issuer on February 12, 2026, at a ratio of one Warrant for every two Shares held as of the record date. Each Warrant entitles the holder to purchase one Share at an exercise price of $8.00 per Warrant subject to the Issuer's right to voluntarily decrease such exercise price in its sole and absolute discretion from time to time. The Warrants are expected to expire and cease to be exercisable on February 11, 2028, unless certain conditions are met for an earlier expiration date.